ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

CBD, Medical Marijuana Are Enticing, But Have Limited Data

by Thomas R. Collins • September 6, 2019

  • Tweet
  • Email
Print-Friendly Version

Rafi Kabarriti, MDI’ve treated a number of patients with head and neck cancer who have used cannabis, … and they seem to tolerate treatment better than the ones who are not using cannabis. —Rafi Kabarriti, MD

You Might Also Like

  • Limited Data Available on Genetic Drivers of HNSCC in Low- Risk Patients
  • Medical Simulation: Limited Funding Limits the Possibilities: Part 2 of 2 articles
  • AAO-HNS Officials Tout Academy’s Clinical Data Registry as Powerful Compliance, Research Tool
  • Medicare Payment Data Release Concerns Some Otolaryngologists
Explore This Issue
September 2019

AMA and ACP Positions

Leading medical associations have published position papers on medical marijuana, but both the American Medical Association and American College of Physicians declined to grant interviews to ENTtoday for further guidance on how physicians can navigate the confusing landscape, saying they had nothing to add beyond the publications already available.

In addition to calling for steps designed to promote additional research into medical marijuana, the American College of Physicians position paper encourages the use of non-smoked forms of THC that have “proven therapeutic value.” The college also urges authorities to do an evidence-based review of marijuana’s status as a Schedule I controlled substance, to see whether it should be reclassified, and “strongly supports” exemption from federal criminal prosecution, civil liability, or professional sanctioning for physicians prescribing or dispensing medical marijuana in accordance with state law.

The AMA also calls for steps for more high-quality research and says it “believes that cannabis for medicinal use should not be legalized through the state legislative, ballot initiative, or referendum process.” The association also says it supports legislation granting immunity to physicians who recommend cannabis for medical conditions in accordance with state laws. Patient care, the policy says, “requires the free and unfettered exchange of information on treatment alternatives and that discussion of these alternatives between physicians and patients should not subject either party to criminal sanctions.”

Although the interest in medical marijuana seems to be keener in neurology, mainly for a role in epilepsy and multiple sclerosis, and rheumatology, which involves many disorders that bring chronic pain, otolaryngologists are also eager to learn more about medical marijuana, Dr. Winkler said. Recently, at a medical meeting in Portland, Ore., a colleague suggested they do a study looking at post-operative pain with or without CBD.

“Right now it seems like CBD oil is the cure-all for everything, which of course it’s not,” he said. “But, that said, what things might it be beneficial for? And we all talk about that, and maybe we’ll do some studies in the near future. … It’s one of those things that we all think could have some potential—just the studies, to my knowledge, haven’t been done. While CBD oil and cannabis may have potential as a therapy for a variety of diseases, we need more well-controlled studies to guide our clinical practices.” 

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features Tagged With: CBD, clinical best practices, Clinical Guidelines, medical marijuanaIssue: September 2019

You Might Also Like:

  • Limited Data Available on Genetic Drivers of HNSCC in Low- Risk Patients
  • Medical Simulation: Limited Funding Limits the Possibilities: Part 2 of 2 articles
  • AAO-HNS Officials Tout Academy’s Clinical Data Registry as Powerful Compliance, Research Tool
  • Medicare Payment Data Release Concerns Some Otolaryngologists

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.